Comparitive open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane 7 and ICRF-187) in patients with advanced breast cancer; treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC)

H. Rosing, W.W. ten Bokkel Huinink, A. Bult, J.H. Beijnen

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)69-77
Number of pages8
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Publication statusPublished - 1999

Cite this